182 related articles for article (PubMed ID: 18355603)
1. Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy.
Sedghizadeh PP; Kumar SK; Gorur A; Schaudinn C; Shuler CF; Costerton JW
J Oral Maxillofac Surg; 2008 Apr; 66(4):767-75. PubMed ID: 18355603
[TBL] [Abstract][Full Text] [Related]
2. Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy.
Sedghizadeh PP; Kumar SK; Gorur A; Schaudinn C; Shuler CF; Costerton JW
J Am Dent Assoc; 2009 Oct; 140(10):1259-65. PubMed ID: 19797556
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate-related osteonecrosis of the jaw: the role of actinomyces.
Naik NH; Russo TA
Clin Infect Dis; 2009 Dec; 49(11):1729-32. PubMed ID: 19886792
[TBL] [Abstract][Full Text] [Related]
4. Histologic and histomorphometric features of bisphosphonate-related osteonecrosis of the jaws: an analysis of 31 cases with confocal laser scanning microscopy.
Favia G; Pilolli GP; Maiorano E
Bone; 2009 Sep; 45(3):406-13. PubMed ID: 19450715
[TBL] [Abstract][Full Text] [Related]
5. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
Carlson ER; Basile JD
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
[TBL] [Abstract][Full Text] [Related]
6. "Bis-phossy jaws" - high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw.
Abu-Id MH; Warnke PH; Gottschalk J; Springer I; Wiltfang J; Acil Y; Russo PA; Kreusch T
J Craniomaxillofac Surg; 2008 Mar; 36(2):95-103. PubMed ID: 18234504
[TBL] [Abstract][Full Text] [Related]
7. Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients.
Walter C; Al-Nawas B; du Bois A; Buch L; Harter P; Grötz KA
Cancer; 2009 Apr; 115(8):1631-7. PubMed ID: 19156913
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonate-associated osteonecrosis of the jaws: the limits of a conservative approach.
Tirelli G; Biasotto M; Chiandussi S; Dore F; De Nardi E; Di Lenarda R
Head Neck; 2009 Sep; 31(9):1249-54. PubMed ID: 19260132
[TBL] [Abstract][Full Text] [Related]
9. Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases.
Alons K; Kuijpers SC; de Jong E; van Merkesteyn JP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Feb; 107(2):e1-7. PubMed ID: 19071040
[TBL] [Abstract][Full Text] [Related]
10. Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases.
Stanton DC; Balasanian E
J Oral Maxillofac Surg; 2009 May; 67(5):943-50. PubMed ID: 19375001
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients.
Kyrgidis A; Vahtsevanos K; Koloutsos G; Andreadis C; Boukovinas I; Teleioudis Z; Patrikidou A; Triaridis S
J Clin Oncol; 2008 Oct; 26(28):4634-8. PubMed ID: 18574158
[TBL] [Abstract][Full Text] [Related]
12. Novel hypotheses in the etiopathogenesis of bisphosphonate-related osteonecrosis of the jaws.
Kyrgidis A
J Oral Maxillofac Surg; 2009 Nov; 67(11):2554. PubMed ID: 19837341
[No Abstract] [Full Text] [Related]
13. [Bisphosphonate-associated osteonecrosis of the jaws. 3. Two case reports].
Schortinghuis J; Meijndert L; de Visscher JG; Witjes MJ
Ned Tijdschr Tandheelkd; 2007 Oct; 114(10):432-5. PubMed ID: 17972612
[TBL] [Abstract][Full Text] [Related]
14. Ozone therapy in the treatment of avascular bisphosphonate-related jaw osteonecrosis.
Agrillo A; Ungari C; Filiaci F; Priore P; Iannetti G
J Craniofac Surg; 2007 Sep; 18(5):1071-5. PubMed ID: 17912085
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
Walter C; Al-Nawas B; Grötz KA; Thomas C; Thüroff JW; Zinser V; Gamm H; Beck J; Wagner W
Eur Urol; 2008 Nov; 54(5):1066-72. PubMed ID: 18602738
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients.
Lazarovici TS; Yahalom R; Taicher S; Elad S; Hardan I; Yarom N
J Oral Maxillofac Surg; 2009 Apr; 67(4):850-5. PubMed ID: 19304045
[TBL] [Abstract][Full Text] [Related]
17. Hyperbaric oxygen treatment and bisphosphonate-induced osteonecrosis of the jaw: a case series.
Freiberger JJ; Padilla-Burgos R; Chhoeu AH; Kraft KH; Boneta O; Moon RE; Piantadosi CA
J Oral Maxillofac Surg; 2007 Jul; 65(7):1321-7. PubMed ID: 17577496
[TBL] [Abstract][Full Text] [Related]
18. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.
King AE; Umland EM
Pharmacotherapy; 2008 May; 28(5):667-77. PubMed ID: 18447663
[TBL] [Abstract][Full Text] [Related]
19. Dental and periodontal history of oncologic patients on parenteral bisphosphonates with or without osteonecrosis of the jaws: a pilot study.
Carmagnola D; Celestino S; Abati S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):e10-5. PubMed ID: 18801674
[TBL] [Abstract][Full Text] [Related]
20. Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy.
Estilo CL; Van Poznak CH; Wiliams T; Bohle GC; Lwin PT; Zhou Q; Riedel ER; Carlson DL; Schoder H; Farooki A; Fornier M; Halpern JL; Tunick SJ; Huryn JM
Oncologist; 2008 Aug; 13(8):911-20. PubMed ID: 18695259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
